The Consideration for Revision of the Korean Medication Algorithm for Schizophrenia.
- Author:
Jung Seo YI
1
;
Yong Min AHN
;
Won Myong BAHK
;
Jun Soo KWON
Author Information
1. Department of Psychiatry, College of Medicine, Hallym University, Seoul, Korea.
- Publication Type:Review
- Keywords:
Korean medication algorithm for schizophrenia;
Pharmacotherapy;
Revision
- MeSH:
Consensus;
Drug Therapy;
Methods*;
Practice Guidelines as Topic;
Psychopharmacology;
Schizophrenia*;
Texas
- From:Korean Journal of Psychopharmacology
2004;15(3):276-283
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
After publishing 2001 version of the Korean Medication Algorithm for Schizophrenia, the strategy of pharmacologic treatment for schizophrenia has been altered with the rapid advancement in the area of psychopharmacology. Currently, the feasibility of this algorithm has been evaluated. Guidelines require updating when significant new evidence appears. Recently, several guidelines of the treatment of schizophrenia including the APA practice guideline, the Expert Consensus Guideline Series and the Texas Medication Algorithm Project (TMAP) Antipsychotic Algorithm for Schizophrenia were revised. In this review, the authors briefly discussed the problems and limitations of the Korean Medication Algorithm for Schizophrenia and presented the direction of future revision on the model of above-mentioned guidelines.
